Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAF(V600E)-mutated metastatic melanoma

Clinical applications of glucocorticoids (GC) in Oncology are dependent on their pro-apoptotic action to treat lymphoproliferative cancers, and to alleviate side effects induced by chemotherapy and/or radiotherapy. However, the mechanism(s) by which GC may also promote tumor progression remains uncl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Main Authors: Estrela, José M, Salvador, Rosario, Marchio, Patricia, Valles, Soraya L, López-Blanch, Rafael, Rivera, Pilar, Benlloch, María, Alcácer, Javier, Pérez, Carlos L, Pellicer, José A, Obrador, Elena
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943348/
https://ncbi.nlm.nih.gov/pubmed/31911848
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares